Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214382 · ClinicalTrials.gov registry record · Phase 3
Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
A Phase 3 study of Roux en Y Gastric Bypass Surgery, sponsored by North Dakota State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT01214382: Completed Phase 3 study of Roux en Y Gastric Bypass Surgery, sponsored by North Dakota State University.
NCT01214382 is a Phase 3 study of Roux en Y Gastric Bypass Surgery that has completed, run by North Dakota State University. The registered enrollment target is 31 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01214382, a Phase 3 study of Roux en Y Gastric Bypass Surgery, has completed, sponsored by North Dakota State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.
Conditions Studied
Interventions
- DRUG Sertraline
Study Locations (1)
North Dakota
- Neuropsychiatric Research Institute - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214382
The ClinicalTrials.gov registry entry for NCT01214382 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Dakota State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Roux en Y Gastric Bypass Surgery appearing as the primary indexed condition, and to 1 intervention - of which Sertraline is the first listed.
NCT01214382 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.
Frequently Asked Questions
What is clinical trial NCT01214382 about?
NCT01214382 is a clinical study titled "Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery". This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatri...
What is the current status of trial NCT01214382?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 31 participants. The study started on 2010-10. Estimated completion is 2014-08.
What conditions does trial NCT01214382 study?
This clinical trial studies the following conditions: Roux en Y Gastric Bypass Surgery.
What interventions are being tested in trial NCT01214382?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT01214382?
This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01214382 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.